Press Releases: Page
Post a press release | Manage press releases
-
Boehringer Ingelheim Launches Discovery Collaboration with Immunai to Identify Novel T-Cell Targets Across Oncology and Autoimmune Disease
Press release from Immunai • June 25, 2026 -
QED Science Launches AI Infrastructure for Scientific Validation
Press release from QED Science • June 24, 2026 -
The Next Bottleneck in AI Drug Discovery Isn't Molecule Design. It's Analytical Validation. Expert Intelligence Launches EI Signal at BIO 2026.
Press release from Tools for AI, Inc dba Expert Intelligence • June 22, 2026 -
Greenstone Biosciences, Inc. and Intel Corp. Launch Strategic Collaboration to Scale Human-Centric Drug Discovery.
Press release from Greenstone Biosciences Inc • June 19, 2026 -
TrialAssure and Cancer Research UK Collaborate to Advance AI-Supported Regulatory Document Authoring
Press release from TrialAssure • June 18, 2026 -
J‑Pharma Co., Ltd. and Uniphar Announce Advancement of Nanvuranlat into Phase 3 Clinical Development Following FDA Alignment and Initial Patient Enrollment
Press release from Uniphar • June 17, 2026 -
Cresset releases Flare V12 to cut synthesis and testing cycles with faster, more flexible FEP
Press release from Cresset • June 16, 2026 -
Receptor.AI and onepot Partner to Shorten the Path from Virtual Hits to Assay-Ready Compounds
Press release from Receptor.AI • June 15, 2026 -
Protai Introduces AIMS-Fold Establishing Structural-Proteomics-Guided AI for Induced Proximity Drug Design
Press release from Protai • June 10, 2026 -
Boston Startup nvisualAI Debuts RFID Solution to Automate Lab Inventory with Real-Time Tracking
Press release from nvisualAI • June 10, 2026 -
Trait Biosciences Reports Exploratory Observational Findings from Water-Soluble Cannabidiol (CBD) Formulation in Companion Animals
Press release from Trait Biosciences • June 9, 2026 -
Kivo and CRISPR Therapeutics to Present 52-Day QMS Modernization at DIA 2026 in Philadelphia
Press release from Kivo • June 9, 2026 -
Neovia Oncology Announces Completion of Phase I(a) Study of NEV-801, a Novel Dual Topoisomerase Drug-Drug Conjugate
Press release from Neovia Oncology • June 6, 2026 -
Almac Diagnostic Services Expand NGS Capabilities for Clinical Trial Research
Press release from Almac Group • June 2, 2026 -
Rayca Precision and ASAKE Partner on AI-Designed Therapeutics for Rare and Metabolic Diseases
Press release from Rayca Precision • June 2, 2026 -
Baptist Health South Florida and The START Center for Cancer Research Announce Strategic Partnership to Expand Patient Access to Early-Phase Cancer Trials
Press release from The START Center for Cancer Research • May 28, 2026 -
Validating the Security Foundation of Its Access Bridge™ Platform
Press release from JDL Access • May 27, 2026 -
Acuity Process Solutions and Eberbach Corporation Announce Strategic Partnership
Press release from Acuity Process Solutions • May 27, 2026 -
ProPharma Appoints Adrian Pencak as Chief Commercial Officer
Press release from ProPharma • May 27, 2026 -
Windfall Bio to auction off high-end research and development instruments via Silicon Valley Disposition
Press release from Silicon Valley Disposition • May 22, 2026
Previous
